{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:16:01Z","timestamp":1790914561081,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10552-008-9221-y","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T15:31:06Z","timestamp":1219937466000},"page":"115-119","source":"Crossref","is-referenced-by-count":43,"title":["Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility"],"prefix":"10.1007","volume":"20","author":[{"given":"Eduardo","family":"Nagore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Botella-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"9221_CR1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccr.2005.11.008","volume":"8","author":"O Kabbarah","year":"2005","unstructured":"Kabbarah O, Chin L (2005) Revealing the genomic heterogeneity of melanoma. Cancer Cell 8:439\u2013441","journal-title":"Cancer Cell"},{"key":"9221_CR2","first-page":"135","volume-title":"Cutaneous melanoma","author":"AC Halpern","year":"2003","unstructured":"Halpern AC, Marghoob AA, Sober AJ (2003) Clinical characteristics. In: Balch CM, Houghton AN, Sober AJ (eds) Cutaneous melanoma, 4th edn. Quality Medical Publishing, Inc., St. Louis, Missouri, pp 135\u2013162","edition":"4"},{"key":"9221_CR3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00000658-198205000-00013","volume":"195","author":"ET Krementz","year":"1982","unstructured":"Krementz ET, Feed RJ, Coleman WP 3rd et al (1982) Acral lentiginous melanoma. A clinicopathologic entity. Ann Surg 195:632\u2013645","journal-title":"Ann Surg"},{"key":"9221_CR4","first-page":"1051","volume":"28","author":"JR Stalkup","year":"2002","unstructured":"Stalkup JR, Orengo IF, Katta R (2002) Controversies in acral lentiginous melanoma. Dermatol Surg 28:1051\u20131059 (discussion 9)","journal-title":"Dermatol Surg"},{"key":"9221_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","volume":"143","author":"C Kuchelmeister","year":"2000","unstructured":"Kuchelmeister C, Schaumburg-Lever G, Garbe C (2000) Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol 143:275\u2013280","journal-title":"Br J Dermatol"},{"key":"9221_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1008872014889","volume":"10","author":"A Green","year":"1999","unstructured":"Green A, McCredie M, MacKie R et al (1999) A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 10:21\u201325","journal-title":"Cancer Causes Control"},{"key":"9221_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2007.08031.x","volume":"157","author":"A Phan","year":"2007","unstructured":"Phan A, Touzet S, Dalle S et al (2007) Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol 157:311\u2013318","journal-title":"Br J Dermatol"},{"key":"9221_CR8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0007-1226(84)90141-3","volume":"37","author":"JC Briggs","year":"1984","unstructured":"Briggs JC (1984) The role of trauma in the aetiology of malignant melanoma: a review article. Br J Plast Surg 37:514\u2013516","journal-title":"Br J Plast Surg"},{"key":"9221_CR9","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T et al (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135\u20132147","journal-title":"N Engl J Med"},{"key":"9221_CR10","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","volume":"12","author":"G Saldanha","year":"2006","unstructured":"Saldanha G, Potter L, Daforno P et al (2006) Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res 12:4499\u20134505","journal-title":"Clin Cancer Res"},{"key":"9221_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.0022-202X.2005.23833.x","volume":"125","author":"J Lang","year":"2005","unstructured":"Lang J, MacKie RM (2005) Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. J Invest Dermatol 125:575\u2013579","journal-title":"J Invest Dermatol"},{"key":"9221_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0022-202X.2004.22722.x","volume":"123","author":"Y Sasaki","year":"2004","unstructured":"Sasaki Y, Niu C, Makino R et al (2004) BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol 123:177\u2013183","journal-title":"J Invest Dermatol"},{"key":"9221_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2340\/00015555-0004","volume":"86","author":"E Nagore","year":"2006","unstructured":"Nagore E, Oliver V, Botella-Estrada R et al (2006) Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Acta Derm Venereol 86:50\u201356","journal-title":"Acta Derm Venereol"},{"key":"9221_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28\u201344","journal-title":"Eur J Cancer"},{"key":"9221_CR15","first-page":"171","volume-title":"Cutaneous melanoma","author":"AN Crowson","year":"2003","unstructured":"Crowson AN, Magro CM, Barnhill RL et al (2003) Pathology. In: Balch CM, Houghton AN, Sober AJ (eds) Cutaneous melanoma, 4th edn. Quality Medical Publishing, Inc., St. Louis, Missouri, pp 171\u2013206","edition":"4"},{"key":"9221_CR16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","volume":"77","author":"CG Clemente","year":"1996","unstructured":"Clemente CG, Mihm MC Jr, Bufalino R et al (1996) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303\u20131310","journal-title":"Cancer"},{"key":"9221_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.2006.07368.x","volume":"155","author":"A Phan","year":"2006","unstructured":"Phan A, Touzet S, Dalle S et al (2006) Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 155:561\u2013569","journal-title":"Br J Dermatol"},{"key":"9221_CR18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archsurg.1995.01430010090019","volume":"130","author":"CA Ridgeway","year":"1995","unstructured":"Ridgeway CA, Hieken TJ, Ronan SG et al (1995) Acral lentiginous melanoma. Arch Surg 130:88\u201392","journal-title":"Arch Surg"},{"key":"9221_CR19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9610(05)80586-0","volume":"166","author":"CM Sutherland","year":"1993","unstructured":"Sutherland CM, Mather FJ, Muchmore JH et al (1993) Acral lentiginous melanoma. Am J Surg 166:64\u201367","journal-title":"Am J Surg"},{"key":"9221_CR20","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ et al (2001) Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635\u20133648","journal-title":"J Clin Oncol"},{"key":"9221_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","volume":"16","author":"E Edlundh-Rose","year":"2006","unstructured":"Edlundh-Rose E, Egyhazi S, Omholt K et al (2006) NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res 16:471\u2013478","journal-title":"Melanoma Res"},{"key":"9221_CR22","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D et al (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340\u20134346","journal-title":"J Clin Oncol"},{"key":"9221_CR23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/95.11.806","volume":"95","author":"DC Whiteman","year":"2003","unstructured":"Whiteman DC, Watt P, Purdie DM et al (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95:806\u2013812","journal-title":"J Natl Cancer Inst"},{"key":"9221_CR24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<843::AID-IJC8>3.0.CO;2-U","volume":"77","author":"DC Whiteman","year":"1998","unstructured":"Whiteman DC, Parsons PG, Green AC (1998) p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 77:843\u2013848","journal-title":"Int J Cancer"},{"key":"9221_CR25","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archderm.1995.01690220060011","volume":"131","author":"F Grange","year":"1995","unstructured":"Grange F, Chompret A, Guilloud-Bataille M et al (1995) Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 131:1154\u20131159","journal-title":"Arch Dermatol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9221-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-008-9221-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9221-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T19:40:45Z","timestamp":1684525245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-008-9221-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["9221"],"URL":"https:\/\/doi.org\/10.1007\/s10552-008-9221-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,29]]}}}